Sanofi's Taxotere among latest Welsh recomendations
This article was originally published in Scrip
Executive Summary
In its latest final appraisals, the All Wales Medicines Strategy Group (AWMSG) has recommended Sanofi-Aventis's Taxotere (docetaxel),Novartis's Exjade (deferasirox) andSchering-Plough's Suboxone (buprenorphine with naloxone) for use in the Welsh national health service.